Drugs / Plasma
Trials 12
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 25 trials · 1 missed | ||||||
| Phase 2 | NCT07094724 | Jul → Nov 2025 overdue | West Nile fever | Gili Regev-Yochay MD | Recruiting | No outcome recorded |
| Phase 2 | NCT04332380 | May → Jul 2020 | Coronaviridae infectious disease | Universidad del Rosario | Completed | No outcome recorded |
| Phase 2 | NCT04358783 | Apr 2020 → May 2021 | COVID-19 | Hospital Universitario Dr. Jose E. Gonzalez | Completed | No outcome recorded |
| Phase 2 | NCT03366220 | Mar 2018 → Sep 2019 | infectious disease with sepsis | The University of Texas Health Science Center, Houston | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT03138317 | Jan 2017 → May 2018 | osteoarthritis, knee | University of Sao Paulo | Unknown | Missed primary |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04332835 | Aug → Oct 2020 | COVID-19 | Universidad del Rosario | Completed | No outcome recorded |
| Phase 34 trials · 1 met primary | ||||||
| Phase 3 | NCT07212998 | Aug 2026 → Aug 2029 expected | — | Jason Sperry | Recruiting | No outcome recorded |
| Phase 3 | NCT06070350 | Nov 2024 → Jun 2028 expected | — | Philip Spinella | Recruiting | No outcome recorded |
| Phase 3 | NCT05634109 | Jan 2023 → Dec 2025 overdue | — | Fundacion Clinica Valle del Lili | Recruiting | No outcome recorded |
| Phase 3 | NCT01818427 | May 2014 → Sep 2017 | — | Jason Sperry | Completed | Met primary |
| Phase 42 trials | ||||||
| Phase 4 | NCT02774317 | Oct 2017 → Jun 2020 | blood coagulation disease | University of Chicago | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT01509274 | Aug 2011 → Jun 2012 | plantar fasciitis | Kolding Sygehus | Unknown | No outcome recorded |
| Comparator or background therapy5 trials | ||||||
| Phase 2 | NCT03981484 Comparator | Jan 2020 → Oct 2022 | blood coagulation disease, hemorrhagic disease | Bellal A. Joseph, MD, FACS | Unknown | No outcome recorded |
| Phase 2/3 | NCT02303964 Comparator | Nov 2014 → Jan 2016 | — | Virginia Commonwealth University | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT05638581 Comparator | Jul 2023 → Aug 2026 | — | University of Alabama at Birmingham | Completed | No outcome recorded |
| Phase 3 | NCT04704869 Background | Jan 2017 → Dec 2021 | — | Bryan Cotton | Completed | Missed primary |
| — | NCT06495294 Comparator | Dec 2024 → Dec 2026 expected | — | Unity Health Toronto | Recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 17 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | plasma | “Participants will receive separated blood components (i.e., units of red cells, plasma, platelets, and cryoprecipitate) co-administered intravenously or intraosseously.” NCT05638581 ↗16“the participant will receive 3 red blood cell units, 3 fresh frozen plasma units, and half of a platelets apheresis, equivalent to 3 platelets units.” NCT05634109 ↗ “Component Therapy (CT) will be RBCs, plasma and platelet units in a 1:1:1 unit ratio.” NCT06070350 ↗ |
| Known as | FFP | “FFP (plasma frozen within 8 hrs of collection) or FP24 (plasma frozen within 24 hrs of collection)” NCT02774317 ↗ |
| Known as | FP24 | “FFP (plasma frozen within 8 hrs of collection) or FP24 (plasma frozen within 24 hrs of collection)” NCT02774317 ↗ |
| Modality | Other / unclassified | “Biological: Transfusion of blood products” NCT05634109 ↗ |
| Route | Other | “3 ml plasma injected once into the plantar fascia” NCT01509274 ↗ |